Linear ubiquitination is a key posttranslational modification that regulates immune signaling and cell death pathways, notably tumor necrosis factor receptor 1 (TNFR1) signaling. The only known enzyme complex capable of forming linear ubiquitin chains under native conditions to date is the linear ubiquitin chain assembly complex, of which the catalytic core component is heme-oxidized iron regulatory protein 2 ubiquitin ligase-1-interacting protein (HOIP). To understand the underlying mechanisms of maintenance of liver homeostasis and the role of linear ubiquitination specifically in liver parenchymal cells, we investigated the physiological role of HOIP in the liver parenchyma. To do so, we created mice harboring liver parenchymal cellspecific deletion of HOIP (Hoip Dhep mice) by crossing Hoip-floxed mice with albumin-Cre mice. HOIP deficiency in liver parenchymal cells triggered tumorigenesis at 18 months of age preceded by spontaneous hepatocyte apoptosis and liver inflammation within the first month of life. In line with the emergence of inflammation, Hoip Dhep mice displayed enhanced liver regeneration and DNA damage. In addition, consistent with increased apoptosis, HOIP-deficient hepatocytes showed enhanced caspase activation and endogenous formation of a death-inducing signaling complex which activated caspase-8. Unexpectedly, exacerbated caspase activation and apoptosis were not dependent on TNFR1, whereas ensuing liver inflammation and tumorigenesis were promoted by TNFR1 signaling. Conclusion: The linear ubiquitin chain assembly complex serves as a previously undescribed tumor suppressor in the liver, restraining TNFR1-independent apoptosis in hepatocytes which, in its absence, is causative of TNFR1-mediated inflammation, resulting in hepatocarcinogenesis. (HEPATOLOGY 2017;65:1963-1978.
cell apoptosis, (3) TNF blockade has been tested in patients suffering from hepatic complications. Indeed, therapies targeting TNF have shown promising results in improving nonalcoholic steatohepatitis in humans. (4, 5) However, by contrast, anti-TNF therapy has not been successful in ameliorating alcoholic hepatitis (6) and, unexpectedly, can even trigger reactivation of hepatitis B virus infection by preventing viral clearance. (7) Thus, dissection of the TNF/TNF receptor 1 (TNFR1) system in distinct etiologies and cell types is crucial to improve the strategy for intervention of liver diseases.
Several studies have revealed a key role for TNFR1 signaling in liver inflammation and cancer in mouse models. For instance, liver parenchymal cell (LPC)-specific IjB kinase (IKK) b-deficient mice are more susceptible to diethylnitrosamine-induced cell death and carcinogenesis. (8) Follow-up studies employing LPCspecific nuclear factor-jB (NF-jB) essential modulator (NEMO) and transforming growth factor b-activated kinase 1 (TAK1) knockout (KO) mice indicated that indeed optimal regulation of TNFR1 signaling is crucial to maintain liver homeostasis and to protect from inflammation and cancer. (9, 10) Importantly, in addition to the regulation of NF-jB, aberrant activation of cell death machineries triggered by deregulated TNFR1 signaling can evoke severe liver pathology. For instance, hepatocyte apoptosis and hepatocarcinogenesis due to LPC-specific TAK1 deficiency are mediated by caspase-8 in those cells, while cholestasis was induced by the necroptosis inducer receptor-interacting protein kinase (RIPK3). (11) Furthermore, transforming growth factor b-activated kinase 1 and the IKKa-IKKb-NEMO complex have been shown to suppress cell death signaling independently of their role in activating NF-jB in hepatocytes and other cell types. (12, 13) Thus, deregulated cell death and/or NF-jB signaling in hepatocytes can result in liver inflammation and carcinogenesis.
Ubiquitination is a crucial posttranslational modification mediated by ubiquitin ligases to define and finetune the biological function of substrate proteins. (14) Notably, the linear ubiquitin chain assembly complex (LUBAC), the only known ubiquitin ligase complex capable of forming linear diubiquitin linkages de novo, (15) has pivotal immunoregulatory and anti-cell death functions in a wide range of innate and adaptive immune signaling pathways, including those triggered by TNFR1. (16) (17) (18) LUBAC is comprised of hemeoxidized iron regulatory protein 2 ubiquitin ligaseinteracting protein (HOIP), heme-oxidized iron regulatory protein 2 ubiquitin ligase (HOIL-1), and SHANK-associated RH domain interacting protein (SHARPIN). (15, 19) Deficiency in HOIP, the catalytic LUBAC component, results in embryonic lethality at mid-gestation due to TNFR1-mediated endothelial cell death. (20) Indeed, HOIP-deficient mouse embryonic fibroblasts display a robust formation of the cell death-inducing signaling platform complex II of TNFR1 signaling, containing Fas-associated with death domain (FADD), caspase-8, RIPK1, and RIPK3, upon TNF stimulation. (20) SHARPIN-null mice (chronic proliferative dermatitis mice or cpdm mice), by contrast, develop TNFR1-dependent multiorgan inflammation, including the liver, with TNFR1-independent aberration in lymphoid tissues. (19, 21, 22) Interestingly, abnormalities in cpdm mice are completely corrected by genetic ablation of RIPK3 and heterozygosity of caspase-8 or epidermal ablation of FADD. (21, 23) These studies collectively corroborate a central role of LUBAC in restraining aberrant activation of TNFR1-induced cell death machineries in order to maintain tissue homeostasis.
Although cpdm mice exhibit liver inflammation, it remains unknown which tissues and cell types contribute to hepatitis. In addition, the physiological role of LUBAC in LPCs remains unknown. Here, we investigated the role of linear ubiquitination and LUBAC in liver inflammation and carcinogenesis by studying mice that lack HOIP, the central and catalytically active component of LUBAC, specifically in LPCs.
Materials and Methods

ANIMALS
All animal studies were conducted according to an appropriate license under the Animals (Scientific Procedures) Act of 1986. HOIP-floxed (Hoip flox ) mice were created from the C57BL/6 embryonic stem cell clone EPD0161_5_A05 from KOMP Repository (http:// www.komp.org) and generated by the Wellcome Trust Sanger Institute (Hinxton, UK). (20) Hoip flox mice were subsequently crossed to albumin promoter-driven Cre recombinase (Alb-Cre) mice (B6.Cg-Tg[Albcre]21Mgn/J) purchased from Jackson Laboratories (Bar Harbor, ME) to delete HOIP in LPCs. TNFR1-deficient mice (B6.129-Tnfrsf1atm1Mak/J) and cluster of differentiation 95 (CD95) death domain (DD)-floxed mice (C57BL/6-Fastm1Cgn/J) were purchased from Jackson Laboratories. Mice were maintained at Charles River (Margate, UK) and UCL Biological Service Unit (London, UK) under specific pathogen-free conditions and a 12-hour dark/light cycle and fed ad libitum. Both males and females were used in the experiments.
OTHER METHODS
For details of histology and immunohistochemistry, immunoprecipitation, flow cytometric analysis of liver immune cells, isolation of mouse primary hepatocytes, cell viability assay, western blotting, tissue RNA extraction, quantitative RT-PCR, and RNA sequencing, see Supporting Information.
Results
HEPATOCYTE-SPECIFIC DELETION OF HOIP LEADS TO LIVER TUMORIGENESIS
To specifically investigate the role of linear ubiquitination in the maintenance of liver homeostasis, we generated mice with LPC-specific deletion of HOIP by crossing Hoip flox mice (20) with Alb-Cre mice. (24) Mice deficient for HOIP in the liver, referred to as Hoip Dhep mice, showed efficient ablation of HOIP protein in primary hepatocytes at 8-9 weeks of age (Supporting Fig. S1A ). The levels of the other two LUBAC components, HOIL-1 and SHARPIN, were mildly reduced by abrogation of HOIP, in line with previous reports on other tissues and cells. (19, 20, 25) TNFR signaling complex pull-down analysis revealed that HOIPdeficient cells produced drastically reduced levels of linear ubiquitination within the TNFR signaling complex (Supporting Fig. S1B ). The residual linear ubiquitination observed in hepatocytes isolated from Hoip Dhep mice is most likely due to an incomplete penetrance of gene deletion by Alb-Cre, which can be seen in substantially reduced yet detectable levels of HOIP in these cells.
Hoip Dhep mice were as viable as Hoip flox littermate controls at least up to 18 months (Supporting Fig. S1C) . However, at this stage the vast majority of Hoip Dhep mice developed macroscopic lesions and nodules in the liver, while age-matched littermate control mice did not show any overt liver pathology (Fig. 1A, top panels) . The size, number, and severity of macroscopic lesions appearing in Hoip Dhep livers were variable, with some mice developing mild (small lesions; 5/13), moderate (multiple lesions and nodules; 5/13), or severe (large nodules and cystic lesions; 3/13) pathology ( Fig. 1A; Supporting Fig. S2A,B) . Histopathological analysis showed that more than half of the Hoip Dhep animals displaying moderate or severe pathology developed hepatocellular carcinoma (HCC) (5/8) and that those which had not developed HCC displayed precancerous anisokaryosis or inflammatory foci (Fig. 1A,B) . The tumor nodules analyzed stained positively for glutamine synthase and were negative for cytokeratin 19, indicating that the tumors originated from the hepatocyte and not the cholangiocyte lineage ( Fig. 1C; Supporting  Fig. S2C ). Of note, glutamine synthase staining showed a diffuse pattern, which is often observed in human HCC. (26) In addition, Hoip Dhep livers displayed focal lipid accumulation, which was occasionally accompanied by inflammation, indicating that Hoip Dhep mice developed steatosis (Supporting Fig. S2D ).
In order to further molecularly characterize the tumors arising in Hoip Dhep mice, we used RNA sequencing to compare the gene expression profiles of nontumor tissue to tumor nodules from Hoip Dhep mice. The expression profiles of all four nodular samples analyzed were clearly distinguished from those of nontumorous samples (Fig. 1D) . The genes which were up-regulated in the nodular samples were predominantly regulators of mitosis and cell cycle progression (Fig. 1E ). This expression signature observed in the tumor samples from Hoip Dhep mice resembles that of the subclass A and G1-G3 of human HCC described by Thorgeirsson's and Zucman-Rossi's groups, respectively, which are correlated with poor prognosis. (27, 28) Thus, HOIP deletion results in late formation of hepatic tumor nodules with overexpressed cell cycle regulatory genes. 
INFLAMMATION ACCOMPANIED BY DNA DAMAGE EMERGES AT EARLY STAGES OF LIFE IN HOIP-DEFICIENT LIVERS
Inflammation is often a crucial step in liver carcinogenesis. In order to decipher whether deletion of HOIP from hepatocytes triggered inflammation, we studied Hoip
Dhep livers within the first months of life. We first tracked the number of leukocytes in the liver by counting hepatic CD45
1 cells from Hoip flox and Hoip Dhep animals from postnatal day 7 up to 8-9 weeks of age. At postnatal days 7 and 15, leukocyte counts were comparable between Hoip flox and Hoip Dhep livers ( Fig. 2A ). Yet, at 4 weeks of age, leukocyte numbers significantly increased in Hoip
Dhep livers compared to control livers ( Fig. 2A) . In accord, elevated levels of Tnf, chemokine (C-C motif) ligand 3 (Ccl3), and chemokine (C-X-C motif) ligand 1 (Cxcl1) were observed at 4 weeks and notably at 2 weeks of age, when inflammation was not detected in Hoip
Dhep livers by leukocyte count (Fig. 2B) . However, the inflammation observed at 4 weeks was transient as the difference in leukocyte numbers between Hoip flox and Hoip Dhep became marginal at 8-9 weeks of age ( Fig. 2A) . Infiltration of myeloid cells was observed at the sites of inflammation in Hoip Dhep livers at 4 weeks of age (Supporting Fig. S3 ). To further investigate whether certain immune cell compartments were particularly involved in the onset of inflammation in Hoip Dhep livers at 4 weeks, we analyzed the various subpopulations of liver cells by flow cytometry. Monocytes/macrophages, granulocytes, CD4
1 and CD8
T cells, and B cells were accumulated in Hoip
Dhep livers compared to control livers ( Fig.  2C ). This result showed that immune cells from both the myeloid and lymphoid compartments are recruited to the inflamed Hoip Dhep livers and participate in inflammatory responses, which coincides with increased production of cytokines. Together, these data indicate that deficiency of HOIP from liver parenchyma elicits an acute immune response in the first 4 weeks of life, followed by a resolution phase between weeks 4 and 9.
Upon liver damage, hepatocytes and liver cell progenitors undergo compensatory proliferation to replenish liver and maintain tissue integrity. (29) Indeed, HOIP deletion resulted in initiation of liver regeneration as a higher number of Ki-67
1 proliferating liver cells in Hoip
Dhep mice compared to littermate controls was detected at 2-4 weeks (Fig. 2D) . Additionally, an inflammatory environment can lead to accumulation of DNA damage and inflammation-associated carcinogenesis. (30) Intriguingly, Hoip Dhep livers presented increased cH2AX 1 foci, which are used as a DNA damage marker (Fig. 2E ). Taken together, HOIP deficiency in LPCs results in transient liver inflammation at early stages of life, and this inflammation is accompanied by a DNA damage response and regeneration of hepatocytes.
HOIP DELETION IN THE LIVER PARENCHYMA RESULTS IN LIVER DAMAGE AND HEPATOCYTE APOPTOSIS PRIOR TO INFLAMMATION
To quantitatively evaluate the extent of liver damage in Hoip Dhep mice, we determined serum alanine aminotransferase (ALT) levels. In agreement with the leukocyte counts, serum levels of ALT from Hoip Dhep mice showed a moderate yet significant surge at 2 weeks, which peaked at 4 weeks and declined between 4 and 8 weeks of age (Fig. 3A) . It is known that the Alb-Cre mice express the Cre recombinase in cholangiocytes (bile duct cells) in addition to hepatocytes. (9) Indeed, values of the bile duct damage marker alkaline phosphatase were significantly elevated in the sera of Hoip Dhep mice and correlated well with the surge in ALT values (Supporting Fig. S4A, left panel) . A minority of Hoip Dhep mice also displayed high levels of serum bilirubin (>0.5 mg/dL), indicating that the animals suffered from cholestasis, which may contribute to liver damage (Supporting Fig. S4A, right panel) . Collectively, these results show that HOIP deletion in LPCs elicits liver damage and hepatocyte death and, importantly, that both of these events predate the onset of inflammation.
We next aimed to identify the event that resulted in inflammation in Hoip Dhep livers at 4 weeks of age. To do so, we performed a histological analysis of Hoip Dhep mice from postnatal day 1 up to 8 weeks of age (Fig.  3B) . While no aberration in Hoip Dhep livers was observed at postnatal day 1, apoptotic bodies in Hoip Dhep livers were detected at postnatal day 7, and they became more prevalent at 2 weeks of age compared to littermate controls. At 4 weeks of age, i.e., at the peak of inflammation ( Fig. 2A) , we detected tissue collapse in addition to apoptotic bodies and ductular reactions (Fig. 3B ). In line with the observation that inflammation was ameliorated at 8 weeks of age ( Fig.  2A) , apoptotic bodies and ductular reactions were also 
attenuated in Hoip
Dhep livers at this stage (Fig. 3B) . Hence, increased cell death appeared to be the first pathological event in HOIP-deficient livers.
To better characterize the type of cell death observed in the absence of HOIP from LPCs, we performed terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling (TUNEL) and cleaved caspase-3 (CC3) stainings. Both TUNEL 1 and apoptotic CC3
1 cells were significantly increased at 2, 4, and 8 weeks of age in Hoip Dhep livers ( Fig. 3C ; Supporting Fig. S4B) . Notably, the number of dead cells was moderately elevated already during the first week of life in Hoip
Dhep livers (Fig. 3C) . Fig. S4C ). In accord, primary hepatocytes from Hoip Dhep mice displayed activation of caspase-3 as well as caspase-8 cleavage in their lysates (Fig. 3D) . No obvious differences in the levels of any of the proapoptotic and antiapoptotic proteins evaluated in HOIP-deficient hepatocytes was observed ( Supporting Fig. S4D ). Of note, we detected increased phosphorylation of IjBa and c-Jun N-terminal kinase (JNK), accompanied by a reduction in the levels of IjBa in Hoip Dhep livers, which is likely a consequence of the ongoing inflammation in these livers (Supporting Fig. S4E ). Taken together, Hoip
Dhep livers exhibit increased hepatocyte death, characterized by prominent activation of caspase-8 and caspase-3 as well as TUNEL positivity. Hence, mice with HOIP deficiency in the liver suffer from hepatocyte apoptosis which precedes the emergence of hepatitis.
HOIP-DEFICIENT HEPATOCYTES ARE MORE SENSITIVE TO APOPTOSIS INDUCTION BUT LESS CAPABLE OF NF-jB ACTIVATION BY VARIOUS IMMUNE RECEPTOR STIMULI
It has been established that LUBAC deficiency leads to aberrant TNFR1 and other immune receptor signaling output, (17, (19) (20) (21) 23) which could account for the increased liver cell death in Hoip Dhep mice. Indeed, HOIP-deficient primary hepatocytes were more sensitive to cell death induction by TNF, CD95 ligand (CD95L/FasL), and polyinosinic:polycytidylic acid (poly(I:C)) but not TNF-related apoptosis-inducing ligand (TRAIL) (Fig. 4A) . We also assessed whether HOIP-deficient hepatocytes have a defect in gene activation. HOIP-deficient primary hepatocytes showed substantially reduced phosphorylation and subsequent degradation of IjBa upon TNF stimulation and a slight reduction in JNK activation (Fig. 4B) . Extracellular signal-regulated kinase (ERK) activation was not observed upon TNF stimulation, yet HOIP-deficient cells had a higher basal level of phosphorylated extracellular signal-regulated kinase (Fig. 4B) . In addition, phosphorylation of IjBa upon stimulation by CD95L or poly(I:C) was decreased in HOIP-deficient hepatocytes, but phosphorylation of JNK was unaltered (Fig.  4C,D) . These results illustrate that HOIP deficiency mainly dampens NF-jB signaling in hepatocytes induced by multiple immune receptor stimuli. Notably, the basal level of phosphorylated IjBa was also reduced in HOIP-deficient cells (Fig. 4B-D 
HOIP SUPPRESSES FORMATION OF THE CELL DEATH-TRIGGERING SIGNALING COMPLEX INDEPENDENTLY OF ITS GENE-ACTIVATING FUNCTION
Because impaired gene activation can result in increased susceptibility to cell death, we next evaluated whether or not the increased sensitivity of HOIPdeficient hepatocytes to TNF-induced cell death is a consequence of impaired NF-jB-induced gene activation. To do so, we treated HOIP-proficient and HOIPdeficient cells with TNF in combination with cycloheximide (CHX). Hoip Dhep hepatocytes were still more susceptible to TNF/CHX-induced death than control cells (Fig. 5A) , demonstrating that HOIP can protect hepatocytes from TNF-induced cell death independently of its role in gene activation. We previously showed that stimulation of HOIP-deficient mouse embryonic fibroblasts results in aberrant formation of TNFR1 complex II, which contains FADD-caspase-8-RIPK1 and is responsible for the increased death observed in these cells. (20) Strikingly, HOIP-deficient hepatocytes displayed robust formation of such a death-triggering complex containing FADD, caspase-8 (full-length and cleaved), RIPK1, and cellular FLICE-like inhibitory protein long isoform (c-FLIP L ), while its formation was limited in HOIP-proficient primary hepatocytes (Fig.  5B , compare the first and second lanes). Intriguingly, this complex was readily formed in the absence of any exogenous stimulation. Hence, this evidence implies that HOIP-deficient hepatocytes die as a consequence of the aberrant formation of this complex and caspase-8 activation.
In sharp contrast to the marked increase in the formation of this complex by HOIP deficiency, abrogation of gene translation by treatment with the inhibitor CHX did not elevate formation of this complex in HOIP-proficient hepatocytes (Fig. 5B , compare the first and fourth lanes). This result demonstrates that failure of gene activation, including that of NF-jB target genes, does not account for the aberrant assembly of the FADD-associated signaling complex that occurs in the absence of HOIP. These results imply that LUBAC exerts a suppressive function in hepatocytes toward formation of the FADD-RIPK1-caspase-8-c-FLIP L -containing complex and caspase-8 activation independently of its geneactivating capacity, which results in promoting protumorigenic events ensuing from cell death (Fig. 5C) . 
TNFR1 DELETION IS NOT SUFFICIENT TO PREVENT THE DEATH OF HOIP-DEFICIENT HEPATOCYTES
HOIP-deficient hepatocytes are more sensitive to TNF-induced cell death (Fig. 4A) . In addition, previous work has demonstrated that the aberrant cell death observed in SHARPIN-deficient and HOIPdeficient mice is rescued by genetic ablation of TNFR1. (19) (20) (21) 23) We therefore hypothesized that exacerbated cell death and inflammation in HOIPdeficient livers was also mediated by TNFR1 signaling. Unexpectedly, however, when we crossed Hoip Dhep livers was similar to that in Hoip Dhep livers as assessed by serum ALT values and histological analysis (Fig. 6A,B) . Furthermore, codeletion of TNFR1 did not reduce the numbers of TUNEL 1 and CC3 1 cells in HOIP-deficient livers (Fig. 6C) 6D ) and TNFR1 ablation did not prevent formation of the FADD-RIPK1-caspase-8-c-FLIP L -containing complex in HOIP-deficient hepatocytes (Fig. 6E) .
As HOIP-deficient hepatocytes were highly sensitive to CD95L (Fig. 4A) Fig. S5A ). Despite the functionally complete deletion of both TNFR1 and the DD of CD95, Cd95-DD
Dhep
Tnfr1
KO Hoip Dhep mice had significantly higher ALT in the serum (Supporting Fig.  S5B ). In accordance, hepatocytes isolated from these animals contain the FADD-associated caspase-8-activating complex to a similar extent as those obtained from Hoip Dhep mice (Supporting Fig. S5C ). Thus, ablating the capacity of CD95 to induce cell death, in addition to fully ablating TNFR1, does not prevent the increase in aberrant cell death which characterizes HOIP-deficient livers.
TNFR1 MEDIATES HEPATITIS AND TUMORIGENESIS UPON LOSS OF HOIP IN THE LIVER
We next evaluated the effect of TNFR1 ablation on hepatitis in Hoip Dhep mice. Remarkably, even though cell death was unaffected in Tnfr1 KO Hoip Dhep livers (Fig. 6) , the number of leukocytes present in these livers was significantly lower than in Hoip Dhep livers (Fig. 7A) . The transcript levels of Tnf and Ccl3 were also markedly decreased in Tnfr1 KO Hoip Dhep livers (Fig. 7B) . Furthermore, the numbers of hepatic myeloid cells as well as CD8
1 T cells and B cells were diminished by TNFR1 ablation (Fig. 7C ). In accordance with attenuated inflammation, DNA damage in Hoip
Dhep livers was significantly alleviated by deletion of TNFR1, as confirmed by cH2AX staining (Fig. 7D) . To evaluate the effect of TNFR1 deletion in tumorigenesis driven by HOIP deficiency, we also analyzed livers of Tnfr1 KO 
Hoip
Dhep mice at 18 months of age. The incidence of macroscopic nodules was considerably reduced in these mice compared to Hoip Dhep mice. Moreover, Tnfr1 KO Hoip Dhep mice displayed decreased lesion numbers and the lesions that did arise were considerably smaller in size than in Hoip Dhep mice (Fig. 7E,F) . Collectively, these results demonstrate that TNFR1 signaling contributes to HOIP deficiency-mediated liver inflammation and carcinogenesis even though exacerbated hepatocyte death, likely the event that triggers these consequences, still occurs in the absence of TNFR1.
Discussion
Here, we evaluated the impact of LUBAC deficiency on liver homeostasis by genetically ablating HOIP, the catalytically active component of LUBAC, in mouse LPCs. LUBAC deficiency in LPCs results in hepatocyte apoptosis, followed by inflammation in the liver within the first month of life and tumorigenesis at 18 months of age. Intriguingly, cell death regulation by LUBAC in hepatocytes is independent of its function in gene activation and, importantly, requires neither TNFR1 nor the DD of CD95 in vivo. Yet, TNFR1 contributes to the inflammatory processes that are likely triggered by the aberrant death of HOIP-deficient hepatocytes and which eventually results in liver carcinogenesis.
The first aberration we detected in HOIP-deleted livers was an increased level of apoptosis at postnatal day 7 before inflammation became noticeable. Patients suffering from chronic hepatitis, including viral hepatitis and nonalcoholic steatohepatitis, display hepatocyte death. (32) In addition, apoptosis can be a potent driver of inflammation and liver tumorigenesis. (11, 33) Apoptotic cells elicit activation of the immune system and production of mediators of inflammation, which can also activate the regenerative process of hepatocytes. In fact, cytokines and growth factors involved in tissue regeneration are linked to tumor promotion. (34, 35) Furthermore, it is possible that the DNA-damaging environment in HOIP-deficient livers is promoted by impaired NF-jB activation in addition to cell death, which was illustrated in the studies using LPC-specific IKKb knockout mice. (8, 34) We therefore postulate that HOIP deletion initially affects liver homeostasis by promoting hepatocyte apoptosis and that this, through facilitating liver inflammation, regeneration, and DNA damage, creates a protumorigenic environment which enables the formation of HCC.
Alb-Cre-mediated target gene deletion occurs gradually from late gestation to approximately 6 weeks of age. (24) Because HOIP deletion in hepatocytes of Hoip Dhep mice is efficiently executed at 8-10 weeks of age, HOIP deletion should be completed by this stage and no new HOIP-depleted cell are generated. Loss of HOIP causes hepatocyte death, yet a fraction of HOIPdeficient cells appear to be able to survive. As the number of HOIP-deleted cells approaches a plateau, the number of newly HOIP-deleted cells declines, which would provide a decreased source of apoptotic cells, hence explaining the kinetics of cell death observed in Hoip Dhep mice. Remarkably, even though cell death and inflammation are resolved during adulthood in Hoip Dhep mice, the events occurring at early stages of life are sufficient to cause liver tumorigenesis late in life.
Unexpectedly, unlike our previous observations in SHARPIN-deficient cpdm mice (19, 21, 23) and HOIP- deficient embryos, (20) LUBAC deficiency-mediated hepatocyte apoptosis does not require TNFR1. Yet intriguingly, the subsequent enhanced leukocyte recruitment observed in mice proficient for TNFR1 is reverted to normal levels by systemic ablation of TNFR1 in mice with HOIP-deficient livers. This evidence indicates that, while the cell death does not require TNFR1, this receptor contributes to the ensuing inflammation. Thus, TNFR1 signaling from nonparenchymal liver cells, including from immune, hepatic stellate, and endothelial cells, might be involved in the development of hepatitis in mice with HOIP-deficient livers. Furthermore, in line with decreased inflammation, TNFR1 ablation significantly reduced cH2AX
1 cells in HOIP-deficient livers. Apart from inflammation, caspase activation observed in HOIP-deficient hepatocytes could also be responsible for the induction of DNA damage by resulting in DNA fragmentation. In fact, DNA damage was not completely inhibited despite the apparent absence of inflammation by TNFR1 deficiency. These results suggest that DNA damage in the liver may be induced as a consequence of both TNFR1-independent caspase activation and TNFR1-dependent inflammation. Previous studies revealed the tumor-promoting role of TNF in carcinogen-induced liver cancer. (35) In accord, TNFR1 ablation prevented tumorigenesis triggered by HOIP deficiency, presumably by inhibiting inflammation and subsequent DNA damage.
HOIP-deficient hepatocytes are sensitized to death induction by triggering of CD95 and toll-like receptor 3 but not TRAIL. While this result suggests CD95 and toll-like receptor 3 as possible candidate receptors for mediating hepatocyte death in Hoip Dhep mice, the liver cell death observed in Hoip Dhep mice could be mediated by entirely other systems capable of inducing cell death and for which a role of LUBAC has not yet been described. In fact, in addition to CD95L and poly(I:C), TNF was capable of enhanced killing of HOIP-deficient compared to HOIP-proficient hepatocytes, yet ablation of TNFR1 alone or the combined deletion of TNFR1 and the DD of CD95 was not sufficient to prevent cell death in the livers of these mice. Of note, inflammation driven by NF-jB essential modulator deficiency in the liver parenchyma is not ameliorated by concomitant LPC-specific abrogation of TNFR1, TRAIL receptor, and/or the DD of CD95. (36) It is therefore tempting to speculate that a yet unidentified immune receptor, or indeed a combination of multiple immune receptors, might be responsible for hepatocyte cell death and the ensuing inflammation upon HOIP deficiency in vivo.
Alternatively, aberrant cell death could be a consequence of spontaneous formation of the killing complex in the absence of an exogenous stimulus. Indeed, loss of cellular inhibitor of apoptosis proteins by Smac mimetic treatment alone results in spontaneous formation of a FADD-RIPK1-caspase-8-containing complex, termed the "ripoptosome," (37, 38) which is reminiscent of the signaling complex present in HOIP-deficient hepatocytes. The ripoptosome is assembled independently of autocrine TNF, TRAIL, and CD95L. (37, 38) Additional recent studies illustrated the crucial role of RIPK1 and its kinase activity in the formation of the FADD-RIPK1-caspase-8 apoptotic signaling complex. (13, 39, 40) In particular, aberrant cell death causative for the inflammatory phenotype that characterizes cpdm mice is completely prevented by genetic inactivation of RIPK1's kinase activity. (41) It would therefore be interesting to interrogate the role of the kinase activity of RIPK1 in aberrant death complex formation and apoptosis driven by HOIP deficiency in hepatocytes.
HOIP deletion in the liver parenchyma results in cancer formation with overexpression of mitotic genes. A class of human HCC with robust up-regulation of mitosis and cell cycle regulators was identified by Thorgeirsson and colleagues, who termed this subclass A and reported a strong correlation with poor prognosis of patients with HCC. (28) Moreover, according to the classification of human HCC by Boyault et al. into subgroups G1-G6, this signature resembles that of the G3 subgroup of hepatitis B virus-free HCC with highly overexpressed cell cycle regulatory genes. (27) In addition, these nodules displayed up-regulation of fetal liver genes as observed in the G1 subgroup. Both the G1 and G3 subgroups belong to the meta-group G1-G3, which is linked to higher genomic instability and which corresponds to subclass A. In summary, the tumor nodules found in Hoip Dhep mice appear to recapitulate the profile of hepatitis B virus-negative human HCC with chromosomal instability and a more unfavorable outcome.
The pathology of Hoip Dhep livers does not mirror the currently most common process of liver carcinogenesis, arising as a consequence of cirrhosis. However, there is an increasing trend of patients suffering from HCC, particularly in the Western world, associated with obesity and metabolic syndrome but without prior history of cirrhosis. (42) In our mouse model, tumor-bearing HOIP-deficient livers exhibited steatotic features, which may indicate some metabolic alterations in hepatocytes. Therefore, Hoip
Dhep livers could imitate the progression of nonalcoholic fatty liver disease to HCC, bypassing a cirrhotic condition. It would therefore be tempting to speculate that HOIP deficiency in the liver could mimic the conditions in nonalcoholic fatty liver disease patients and could possibly serve as a model for its etiology. The pathologies found in Hoip Dhep livers appear to be driven by aberrant cell death, which is often seen in hepatitis patients. It is therefore possible to envisage that blockade of cell death may be of therapeutic benefit for patients suffering liver complications including nonalcoholic fatty liver disease. Indeed, the caspase inhibitor emricasan (IDN-6556) has been shown to alleviate liver damage in human patients, (43) and a clinical trial testing its effects on nonalcoholic steatohepatitis and liver fibrosis is currently under way (ClinicalTrials.gov identifier NCT02686762).
In conclusion, LUBAC is a previously unidentified tumor suppressor inhibiting hepatocyte apoptosis at postnatal stages that does not require TNFR1. In the absence of LUBAC, a tumor-conducive inflammatory environment emerges in these livers which have suffered from hepatocyte apoptosis followed by compensatory proliferation. The development of this environment involves hepatitis and DNA damage, which, in turn, are dependent on TNFR1. These results identify LUBAC as a crucial factor ensuring hepatocyte survival and as a suppressor of hepatitis and hepatocarcinogenesis.
